Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. | |
| M*A*S*H's 'Trapper John' makes his mark as an investor December 8, 2009 at 5:30 pm |
| Filed under: Economy, People, Investing, Media On M*A*S*H, Wayne Rogers played Trapper John McIntyre, second banana to Alan Alda's Hawkeye Pierce. But when it comes to money management, Rogers has long since established himself as the show's top alumni. While his former colleagues Gary Berghoff (Radar O'Reilly), Mike Farrell (BJ Hunnicut) and William Christopher (Father Mulcahy) have, respectively, moved on to second acts as an inventor, a political activist and a spokesperson for autism awareness, Rogers has emerged as a brilliant investor and business owner. In addition to his chairmanship of Kleinfeld Bridal, a world-renowned bridal store, he is CEO of a chain of convenience stores, principal owner of a Mississippi barge line, and is on the board of directors of Vishay Intertechnology (VSH), which was on Forbes' 2007 list of the top 100 mid-cap stocks. His next venture, he tells the San Francisco Chronicle, will be to focus his investments on depressed real estate and failed banks.Continue reading M*A*S*H's 'Trapper John' makes his mark as an investor M*A*S*H's 'Trapper John' makes his mark as an investor originally appeared on DailyFinance on Tue, 08 Dec 2009 17:30:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| Top publishers link arms in e-reader push December 8, 2009 at 4:45 pm |
| Filed under: Technology, Media, Time Warner, News Corp. An existential crisis, like politics, makes for strange bedfellows. So it is that five media companies that spend most of their time in bitter competition with one another are now joining forces in a new venture intended to midwife the arrival of portable digital magazines and newspapers on a mass scale. So new is this venture, it doesn't yet have a name or an executive team. What it does have is five owners who collectively represent most of the magazines and a goodly segment of the newspapers Americans read: News Corp. (NWS), Time Warner (TWX), Hearst, Conde Nast and Meredith (MDP). Marshaling so much muscle might seem like overkill, but it's in keeping with the scale of the challenge, John Squires, who's serving as managing director until a CEO can be chosen, tells DailyFinance. "It's a huge undertaking, both technically and from a creative standpoint," he says.Continue reading Top publishers link arms in e-reader push Top publishers link arms in e-reader push originally appeared on DailyFinance on Tue, 08 Dec 2009 16:45:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| Downgrades, bad reports, rising dollar push stocks down December 8, 2009 at 4:35 pm |
| Filed under: Investing, Earnings, McDonald's, 3M, Federal Express Stocks fell Tuesday as worries about several world economies sent investors running to the safety of the U.S. dollar and Treasuries. Disappointing reports from key U.S. companies 3M Co. (MMM) and McDonald's (MCD) also increased fears that companies will be hard pressed to produce real profits next year as the economic recovery limps along. The Dow Jones industrial average ($INDU) fell 104 points, or 1%, to 10,285. The Standard & Poor's 500 index ($INX) fell 11 points, or 1%, to 1,091. The the Nasdaq ($COMPX) composite index fell 16.6 points, or 0.76%, to 2,173. The Dow was down as much as 140 points in morning trading.Continue reading Downgrades, bad reports, rising dollar push stocks down Downgrades, bad reports, rising dollar push stocks down originally appeared on DailyFinance on Tue, 08 Dec 2009 16:35:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| New drug is good news for cancer patients, but not for its maker's stock December 8, 2009 at 2:00 pm |
| Filed under: Company News, Healthcare, Johnson & Johnson New Jersey-based drug company Celgene (CELG) on Monday reported highly anticipated data for Revlimid, its multiple myeloma cancer pill. And it didn't disappoint: at the annual American Society of Hematology meeting, Celgene showed that Revlimid reduced the risk of progression by 50% among newly diagnosed patients who used the drug and chemotherapy, followed by maintenance therapy, compared with those who only used chemotherapy. Patients who used Revlimid longer saw a 75% risk reduction, and 92% were alive after one year.Continue reading New drug is good news for cancer patients, but not for its maker's stock New drug is good news for cancer patients, but not for its maker's stock originally appeared on DailyFinance on Tue, 08 Dec 2009 14:00:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| The 'catastrophe bond' market is heading to a surprisingly healthy 2009 December 8, 2009 at 1:00 pm |
| Filed under: Company News, Investing, Goldman Sachs , Marsh & McLennan Cos., American International Group, INC. In an odd twist of logic, it's looking like a good year to be in the catastrophe business. The business of insuring against catastrophes, that is. Industry insiders now expect that catastrophe bond activity will pass the $3 billion mark for 2009, which didn't really seem possible just did six months ago. Four more of these risk-transfer transactions are likely to be completed this month, Reuters reports, which would comfortably push the total to that mark. This comes after the market was bolstered by 2008 deals that were deferred to 2009 and a second quarter that was slower than usual.
Continue reading The 'catastrophe bond' market is heading to a surprisingly healthy 2009 The 'catastrophe bond' market is heading to a surprisingly healthy 2009 originally appeared on DailyFinance on Tue, 08 Dec 2009 13:00:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| Dan Solin: The lowdown on annuities December 8, 2009 at 12:30 pm |
| Filed under: Retirement, Columns, Investing There are many different kinds of annuities. I am going to describe the two most popular ones: deferred variable annuities and equity-indexed annuities -- and one that isn't popular but should be: fixed immediate annuities. Deferred Variable Annuities With deferred variable annuities, you pay the insurance company a lump sum. Your money is invested based upon your selection of the investment options provided by the insurance company. The invested funds grow tax-deferred until you start taking distributions. You cannot access your funds without a tax penalty before the age of 59½ . Sales people gush about the "death benefit," which is guaranteed to be at least the total of the amount contributed, less any withdrawals. However, these are long-term investments. It is highly unlikely that when the insured dies, the account will be underwater.
Continue reading Dan Solin: The lowdown on annuities Dan Solin: The lowdown on annuities originally appeared on DailyFinance on Tue, 08 Dec 2009 12:30:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| Will RIM's BlackBerry do better than Apple's iPhone in China? December 8, 2009 at 10:15 am |
| Filed under: Technology, Research In Motion, Apple, China Mobile Research in Motion (RIMM) sealed a distribution deal for its BlackBerry in China in a partnership with Legend, the owner of Lenovo, on December 7. A day later, the handset company said it had another distribution deal with China Mobile (CHL), the largest cellular carrier in China. The new initiative will be aimed at consumers and small businesses. Bigger companies have been offering BlackBerries for two years. There is reason to curb enthusiasm about the RIM announcement, even though China has over 600 million cellular subscribers, more than twice as many as there are in the US. And market penetration is low enough in the nation of almost 1.4 million people that the cellular phone business is still a growth industry. Continue reading Will RIM's BlackBerry do better than Apple's iPhone in China? Will RIM's BlackBerry do better than Apple's iPhone in China? originally appeared on DailyFinance on Tue, 08 Dec 2009 10:15:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments |
| Stocks in the news: FedEx, Kroger, 3M, McDonald's December 8, 2009 at 9:00 am |
| Filed under: Company News, Investing FedEx (FDX) lifted its earnings guidance due to improved activity. It boosted its profit target to $1.10 a share from its previous estimate of 65 cents to 95 cents a share. The new guidance is well ahead of the Wall Street estimate of 85 cents a share in a survey of analyst by FactSet Research. Shares jumped nearly 2.5% in pre-market trading. The Kroger Co. (KR) says it lost $875 million in its third quarter due to tough price competition and the struggling California economy. Kroger also cut its profit and sales forecast for the full year. Without a write-down, profit would have been $176.7 million, or 27 cents, far below analyst estimates of earnings of 36 cents a share. Shares sank 9% ahead of the bell.Continue reading Stocks in the news: FedEx, Kroger, 3M, McDonald's Stocks in the news: FedEx, Kroger, 3M, McDonald's originally appeared on DailyFinance on Tue, 08 Dec 2009 09:00:00 EST. Please see our terms for use of feeds. Permalink | Email this | Comments | | |